Joshua Chazaro
Analyst-Equity at Evercore Group LLC
Profile
Joshua Chazaro is currently an Analyst at Evercore Group LLC.
Previously, he worked as a Business Development Manager at iHealthScreen, Inc. from 2021 to 2022, and as an Associate at Canaccord Genuity LLC from 2022 to 2024.
Dr. Chazaro holds a doctorate degree from Loyola University of Chicago and an undergraduate degree from the University of California, Riverside.
Joshua Chazaro active positions
Companies | Position | Start |
---|---|---|
Evercore Group LLC
Evercore Group LLC Investment Banks/BrokersFinance Evercore Group LLC is a SEC-registered broker/dealer headquartered in New York City. The firm was founded in 1995 and is a subsidiary of Evercore BD Investco LLC, which is owned by Evercore, Inc. (NYSE: EVR). Evercore Group delivers equity research and equity sales and agency trading execution, in addition to providing wealth and investment management services to high net worth and institutional investors. | Analyst-Equity | 2024-02-29 |
Former positions of Joshua Chazaro
Companies | Position | End |
---|---|---|
Canaccord Genuity LLC
Canaccord Genuity LLC Investment Banks/BrokersFinance Canaccord Genuity LLC is an independent, full-service financial services firm headquartered in New York City. The firm was founded in 2004 and provides a full spectrum of brokerage services to corporate and institutional clients. They cover a wide range of sectors globally with an emphasis on growth companies such as: Block chain, Business Services, Cannabis, Consumer and Retail, Energy, Financials, Gaming, Healthcare, Industrials, Metals and Mining, Real Estate, Sustainability and Technology. | Analyst-Equity | 2024-01-31 |
iHealthScreen, Inc.
iHealthScreen, Inc. Packaged SoftwareTechnology Services iHealthScreen, Inc. is a clinical-stage medical diagnostic and device company that has developed an AI and telemedicine-based platform called iPredict. The company is based in Richmond Hill, NY. The platform is HIPAA compliant and is used for automated screening and prediction of individuals at risk of developing late age-related AMD, diabetic retinopathy (DR), glaucoma, cardiovascular heart disease, and stroke. The company was founded in 2015 by Alauddin Bhuiyan, who has been the CEO since 2015. | Corporate Officer/Principal | 2021-12-31 |
Training of Joshua Chazaro
Loyola University of Chicago | Doctorate Degree |
University of California, Riverside | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 3 |
---|---|
Evercore Group LLC
Evercore Group LLC Investment Banks/BrokersFinance Evercore Group LLC is a SEC-registered broker/dealer headquartered in New York City. The firm was founded in 1995 and is a subsidiary of Evercore BD Investco LLC, which is owned by Evercore, Inc. (NYSE: EVR). Evercore Group delivers equity research and equity sales and agency trading execution, in addition to providing wealth and investment management services to high net worth and institutional investors. | Finance |
Canaccord Genuity LLC
Canaccord Genuity LLC Investment Banks/BrokersFinance Canaccord Genuity LLC is an independent, full-service financial services firm headquartered in New York City. The firm was founded in 2004 and provides a full spectrum of brokerage services to corporate and institutional clients. They cover a wide range of sectors globally with an emphasis on growth companies such as: Block chain, Business Services, Cannabis, Consumer and Retail, Energy, Financials, Gaming, Healthcare, Industrials, Metals and Mining, Real Estate, Sustainability and Technology. | Finance |
iHealthScreen, Inc.
iHealthScreen, Inc. Packaged SoftwareTechnology Services iHealthScreen, Inc. is a clinical-stage medical diagnostic and device company that has developed an AI and telemedicine-based platform called iPredict. The company is based in Richmond Hill, NY. The platform is HIPAA compliant and is used for automated screening and prediction of individuals at risk of developing late age-related AMD, diabetic retinopathy (DR), glaucoma, cardiovascular heart disease, and stroke. The company was founded in 2015 by Alauddin Bhuiyan, who has been the CEO since 2015. | Technology Services |
- Stock Market
- Insiders
- Joshua Chazaro